Sentence examples for expectancy of 3 months from inspiring English sources

One third of the palliative inpatients had a life expectancy of 3 months or less.

Eligibility included ECOG performance status 0-2, minimum life expectancy of 3 months and measurable disease.

Selection criteria included: age ⩾18 years, Karnofsky performance status (PS) ⩾70 and a life expectancy of 3 months.

Patients were required to have a life expectancy of 3 months or longer, and no evidence of infection.

Eligibility criteria included patients with cytologically or histologically confirmed colorectal cancer, with disease progression or toxicity after receiving bevacizumab plus oxaliplatin-based therapy as first-line treatment of more than four cycles, 20 years of age or older, ECOG performance status of 0 or 1, life expectancy of 3 months or longer, and sufficient organ function.

The inclusion criterion included an estimated life expectancy of 3 months or more and an Eastern Cooperative Oncology Group Performance Status Score of 0 to 3 to represent varying degrees of disabilities but sufficient function to complete the assessments (Oken et al, 1982).

Exclusion criteria included concurrent malignancy (excluding basal and squamous-cell skin cancers), concurrent anti-cancer therapy, expected life expectancy of <3 months, active bacterial or fungal systemic infections, or HIV or Hepatitis B or C positivity by serology.

Eighty patients died within the 22-month follow-up period with an average life expectancy of 7.4 months.

In an update later on Wednesday, the inspector general's office said the bureau had issued a memorandum on Tuesday setting the medical criteria for consideration for the program as a terminal disease with life expectancy of 18 months or less.

To be eligible for study, patients had to be at least 18 years old, have an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1, and have life expectancy of >3 months.

Results: Compared with the symptom-based approaches, monitoring CD4 counts every 6 months and starting treatment at a threshold of 200/μL was associated with a gain in life expectancy of 6.5 months (61.9 months vs 68.4 months) and a discounted lifetime cost savings of US $464 per person (US $4069 vs US $3605, discounted 2007 dollars).